pravastatin has been researched along with capecitabine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| de Jongh, FE; Eskens, FA; Konings, IR; Sleijfer, S; van der Gaast, A; van der Wijk, LJ | 1 |
| Cornejo-Uixeda, S; Escoin-Pérez, C; Hernandez-Lorente, E | 1 |
| Gao, M; Johnston, RK; Matthews, AB; Skolnick, J; Snell, TW; Zhou, H | 1 |
1 review(s) available for pravastatin and capecitabine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for pravastatin and capecitabine
| Article | Year |
|---|---|
The addition of pravastatin to chemotherapy in advanced gastric carcinoma: a randomised phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pravastatin; Stomach Neoplasms | 2010 |
3 other study(ies) available for pravastatin and capecitabine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Capecitabine-induced pancreatitits.
Topics: Abdomen, Acute; Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Combined Modality Therapy; Fenofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Oxaliplatin; Pancreatitis; Pravastatin; Sigmoid Neoplasms | 2018 |
Repurposed FDA-approved drugs targeting genes influencing aging can extend lifespan and healthspan in rotifers.
Topics: Aging; Animals; Capecitabine; Databases, Pharmaceutical; Drug Evaluation, Preclinical; Drug Repositioning; Erythromycin; Female; Genes, Helminth; Glutamates; Healthy Aging; Longevity; Male; Models, Animal; Pravastatin; Reproduction; Rotifera; United States; United States Food and Drug Administration; User-Computer Interface | 2018 |